Breaking News Instant updates and real-time market news.

GOOG

Alphabet

$1,298.76

-10.6 (-0.81%)

, GOOGL

Alphabet Class A

$1,297.98

-10 (-0.76%)

17:05
11/11/19
11/11
17:05
11/11/19
17:05

State AGs gather in Colorado to go over Google antitrust probe, Reuters says

State attorneys general are convening on Monday in Colorado to review their probe into whether Google's (GOOG) business practices violate antitrust law, Reuters' Karen Freifeld and Diane Bartz report, citing two sources knowledgeable about the meeting. Roughly a dozen states were expected to send representatives to the meeting, the authors note. The gathering was anticipated to be similar to one held last month, where state and federal enforcers from the DOJ and FTC discussed their investigation of Facebook (FB), the authors say. Reference Link

GOOG

Alphabet

$1,298.76

-10.6 (-0.81%)

GOOGL

Alphabet Class A

$1,297.98

-10 (-0.76%)

FB

Facebook

$189.57

-1.29 (-0.68%)

GOOG Alphabet
$1,298.76

-10.6 (-0.81%)

11/11/19
UBSW
11/11/19
NO CHANGE
Target $240
UBSW
Buy
Nvidia price target raised to $240 ahead of earnings, DC product launch at UBS
UBS analyst Timothy Arcuri raised his price target on Nvidia shares to $240 from $195 ahead of the company's October quarter earnings report. He models quarterly revenue and EPS of $2.91B and $1.61, respectively, which he notes is "more or less" in-line with consensus, but he still sees a path higher for the stock despite the fact that it has outperformed both the S&P 500 and S&P 500 Semis by a "wide margin" over the last three months. Data is starting to play out to prove strength in gaming as ray tracing becomes standard and in the data center as the new 7nm product should be announced next week, said Arcuri. He thinks "performance-focused" customers like Google (GOOGL) are waiting for this new 7nm product and that others are building it into their 2020 roadmaps, the analyst added.
11/07/19
PIPR
11/07/19
NO CHANGE
Target $39
PIPR
Neutral
TripAdvisor price target lowered to $39 from $52 at Piper Jaffray
Piper Jaffray analyst Michael Olson lowered his price target for TripAdvisor (TRIP) shares to $39 from $52 after the company reported weak Q3 revenue and EBITDA and lowered its FY19 EBITDA growth expectation. He believes Google's (GOOGL) "increased aggressiveness" in travel, including placing more emphasis on its own hotel offerings and driving free links farther down the page, is hurting TripAdvisor as well as other online travel players, Olson tells investors. TripAdvisor, and others, may have to turn to higher cost marketing channels to drive similar traffic or face further top-line challenges, contends the analyst, who keeps a Neutral rating on the TripAdvisor shares.
11/06/19
DADA
11/06/19
NO CHANGE
Target $20
DADA
Buy
Sonos rallies after DA Davidson calls 'natural acquisition target' for Apple
DA Davidson analyst Tom Forte reiterates a Buy rating on Sonos (SONO) with a $20 price target following Alphabet's (GOOG, GOOGL) acquisition of Fitbit (FIT). The stock in early trading is up 82c to $14.28. The analyst sees Sonos as the most likely company he covers to have its shares rally from either an improvement in investor perception or a takeover. Sonos is the "best house" on the "bad block" of hardware companies, and is "adjacent to the mansion on the neighboring block, Apple (AAPL)," Forte tells investors in a research note. Similar to Apple, Sonos makes products that are superior to the competition, has an eye for design, and boasts a premium brand that enables it to sell its products at higher prices than others, the analyst says. Further, Forte believes that similar to Fitbit not getting proper credit for its healthcare-related efforts, Sonos does not get credit for its superior technology and premium brand. As such, he sees Sonos as a "natural acquisition target for Apple." Furthermore, while less obvious than Apple, Amazon (AMZN) could acquire Sonos to advance its connected home efforts, according to Forte. The analyst also thinks the company could go private given the "lack of appreciation by Wall Street."
11/04/19
SPHN
11/04/19
INITIATION
Target $12
SPHN
Overweight
Stephens starts Rubicon Project at Overweight with $12 price target
Stephens analyst Kyle Evans initiated coverage of Rubicon Project with an Overweight rating and $12 price target. He views the stock as "a smart way" to invest in the consolidation of programmatic ad spending at a reasonable valuation. He believes likely near-term catalysts of supply path optimization tailwinds and the likely success of its Demand Manager product outweigh risks of take rate pressure and the possibility that Google's (GOOGL) ad tech platform ends up spun-out or independent, Evans tells investors.
GOOGL Alphabet Class A
$1,297.98

-10 (-0.76%)

11/11/19
LOOP
11/11/19
NO CHANGE
Target $1450
LOOP
Hold
Alphabet price target raised to $1,450 from $1,350 at Loop Capital
Loop Capital analyst Alan Gould raised his price target on Alphabet to $1,450, rolling forward his valuation model to 2021 and noting that the company's fundamentals remains strong while its growth in advertising revenue continues at unprecedented scale. The analyst is keeping his Hold rating on Alphabet however, stating that the current regulatory environment poses a growing challenge with no expected improvement over the next 12 months.
11/08/19
DADA
11/08/19
NO CHANGE
Target $44
DADA
Buy
TripAdvisor price target lowered to $44 from $55 at DA Davidson
DA Davidson analyst Tom White lowered his price target on TripAdvisor (TRIP) to $44 after its "disappointing" Q3 results as the company's core Hotels, Media & Platform segment revenue fell 12% while leading to a cut in its 2019 EBITDA growth outlook to "single-digits" from "double-digit". The analyst notes that the competitive Google (GOOGL) SEO issues are unlikely to abate in 2020, but he is keeping his Buy rating on the stock, noting that Tripadvisor is making progress in accelerating its ongoing transformation into a hotel/lodging business that relies less on auction-based ad spend.
11/08/19
JMPS
11/08/19
DOWNGRADE
JMPS
Market Perform
Expedia downgraded to Market Perform from Outperform at JMP Securities
JMP Securities analyst Andrew Boone downgraded Expedia (EXPE) to Market Perform from Outperform after its Q3 earnings miss and guidance cut. The analyst believes that the SEO issues revealed in the quarter will likely persist as a headwind to profitability and cash flow. Boone adds that Vrbo will require more time to benefit from rebranding. The analyst also expects Goolge's (GOOGL) vacation travel ad product and rental module to pose competitive threats to Expedia.
FB Facebook
$189.57

-1.29 (-0.68%)

11/05/19
11/05/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Facebook (FB) upgraded to Buy from Outperform at Daiwa with analyst Satoshi Tanaka saying the company's Q3 results and 2020 outlook last week go a "long way to alleviate concerns." 2. Beyond Meat (BYND) upgraded to Outperform from Market Perform at Bernstein with analyst Alexia Howard saying she is making a "straightforward valuation call" with the shares down 66% from their peak. 3. NXP Semiconductors (NXPI) upgraded to Buy from Neutral at Mizuho with analyst Vijay Rakesh saying the company's auto segment is showing signs of recovery, with easier compares and content wins. 4. Amgen (AMGN) upgraded to Overweight from Neutral at Cantor Fitzgerald with analyst Alethia Young saying recent events have set the stage for a "clean base business and pipeline story" for Amgen in 2020. 5. Autoliv (ALV) upgraded to Buy from Neutral at Mizuho with analyst Vijay Rakesh saying an improving 2020-2021 auto outlook with easier compares, continued airbag market share gains versus Takata, and lower product launch costs position Autoliv well. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/05/19
DAIW
11/05/19
UPGRADE
Target $250
DAIW
Buy
Daiwa upgrades Facebook to Buy, says earnings concerns 'largely alleviated'
Daiwa analyst Satoshi Tanaka last night upgraded Facebook to Buy from Outperform with a price target of $250, up from $235. The company's Q3 results and 2020 outlook last week go a "long way to alleviate concerns," Tanaka tells investors in a research note. The analyst sees "clearer visibility" from 2020 as well as higher upside after the stock's recent pullback. Facebook's revenue growth slowdown is more moderate than previously anticipated while its guidance for total expenses remains within expectations, contends the analyst. He believes the "negative repercussions" stemming from the implementation of Europe's new data protection regulation and Facebook's data leak "controversy are clearer now that a year has passed." Concerns on the earnings front "have largely been alleviated," says Tanaka.
11/04/19
DAIW
11/04/19
UPGRADE
DAIW
Buy
Facebook upgraded to Buy from Outperform at Daiwa
11/04/19
SPHN
11/04/19
INITIATION
Target $250
SPHN
Overweight
Stephens starts Trade Desk at Overweight, touts model compared to Netflix, Roku
Stephens analyst Kyle Evans initiated coverage of Trade Desk (TTD) with an Overweight rating and $250 price target, stating that he believes investors should own the stock because the company has "a more distributed, defendable and profitable business model" than Netflix (NFLX) or Roku (ROKU) with fewer regulatory risks than Google (GOOGL) or Facebook (FB), although he added that the stock is "volatile and expensive." He sees the catalysts of connected TV tailwinds and international growth outweighing the risks of a premium multiple and the growth of ad-free streaming TV options, Evans added.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
12/06/19
12/06
13:17
12/06/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
12/06/19
12/06
13:16
12/06/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,749.41

8.82 (0.51%)

13:08
12/06/19
12/06
13:08
12/06/19
13:08
Periodicals
Amazon says U.K. soccer streams brought record Prime sign-ups, Guardian says »

Amazon has said that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BKR

Baker Hughes

$22.28

0.14 (0.63%)

13:05
12/06/19
12/06
13:05
12/06/19
13:05
Hot Stocks
Baker Hughes reports U.S. rig count down 3 to 799 rigs »

Baker Hughes reports the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LDOS

Leidos

$89.77

-0.14 (-0.16%)

, PSN

Parsons

$40.51

0.66 (1.66%)

13:00
12/06/19
12/06
13:00
12/06/19
13:00
Recommendations
Leidos, Parsons analyst commentary  »

Wells says investors…

LDOS

Leidos

$89.77

-0.14 (-0.16%)

PSN

Parsons

$40.51

0.66 (1.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

SPY

SPDR S&P 500 ETF Trust

$315.21

3.17 (1.02%)

, VOO

Vanguard S&P 500 ETF

$289.57

2.94 (1.03%)

12:58
12/06/19
12/06
12:58
12/06/19
12:58
Technical Analysis
On The Fly: ETF fund flow highlights »

For the week flows to the…

SPY

SPDR S&P 500 ETF Trust

$315.21

3.17 (1.02%)

VOO

Vanguard S&P 500 ETF

$289.57

2.94 (1.03%)

XLY

Consumer Discretionary Sector SPDR

$121.97

1.19 (0.99%)

XLI

Industrial Select Sector SPDR

$81.21

1.08 (1.35%)

IEF

iShares 7-10 Year Treasury Bond ETF

$110.99

-0.34 (-0.31%)

GLD

SPDR Gold Shares

$137.61

-1.4 (-1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$234.00

0.56 (0.24%)

, JNJ

Johnson & Johnson

$141.00

1.43 (1.02%)

12:53
12/06/19
12/06
12:53
12/06/19
12:53
Hot Stocks
FDA approves Amgen's Avsola »

The U.S. Food and Drug…

AMGN

Amgen

$234.00

0.56 (0.24%)

JNJ

Johnson & Johnson

$141.00

1.43 (1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

  • 09

    Dec

  • 21

    Jan

SYPR

Sypris Solutions

$0.82

(0.00%)

, UTX

United Technologies

$147.18

1.87 (1.29%)

12:52
12/06/19
12/06
12:52
12/06/19
12:52
Hot Stocks
Sypris subsidiary wins contracts with United Technologies' Collins Aerospace »

Sypris Electronics, a…

SYPR

Sypris Solutions

$0.82

(0.00%)

UTX

United Technologies

$147.18

1.87 (1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

LDOS

Leidos

$89.47

-0.44 (-0.49%)

12:49
12/06/19
12/06
12:49
12/06/19
12:49
Hot Stocks
Leidos among team awarded DOE contract for Hanford site services »

The U.S. Department of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMMU

Immunomedics

$20.38

1.86 (10.04%)

12:45
12/06/19
12/06
12:45
12/06/19
12:45
Options
Immunomedics call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

12:45
12/06/19
12/06
12:45
12/06/19
12:45
General news
Breaking General news story  »

Week of 12/6 Baker-Hughes…

12:45
12/06/19
12/06
12:45
12/06/19
12:45
General news
Breaking General news story  »

Week of 12/6 Baker-Hughes…

12:40
12/06/19
12/06
12:40
12/06/19
12:40
General news
Treasury's $25 B 2-year FRN reopening stopped at 0.245% »

Treasury's $25 B…

12:40
12/06/19
12/06
12:40
12/06/19
12:40
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

12:30
12/06/19
12/06
12:30
12/06/19
12:30
General news
Treasury's $25 B 2-year FRN reopening stopped at 0.245% »

Treasury's $25 B…

PIR

Pier 1 Imports

$7.70

-0.27 (-3.39%)

12:22
12/06/19
12/06
12:22
12/06/19
12:22
Periodicals
Pier 1 hired Guggenheim amid concerns over debt, Debtwire reports »

Pier 1 Imports has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDLA

Medallia

$29.11

-0.68 (-2.28%)

12:19
12/06/19
12/06
12:19
12/06/19
12:19
Recommendations
Medallia analyst commentary  »

Oppenheimer says would…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

PIR

Pier 1 Imports

$7.92

-0.05 (-0.63%)

12:19
12/06/19
12/06
12:19
12/06/19
12:19
Periodicals
Breaking Periodicals news story on Pier 1 Imports »

Pier 1 hired financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
12/06/19
12/06
12:17
12/06/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
12/06/19
12/06
12:16
12/06/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$60.70

1.195 (2.01%)

, XLRN

Acceleron

$48.58

-0.08 (-0.16%)

12:08
12/06/19
12/06
12:08
12/06/19
12:08
Hot Stocks
Bristol-Myers, Acceleron: FDA says Reblozyl will not be reviewed at ODAC meeting »

Bristol-Myers Squibb…

BMY

Bristol-Myers

$60.70

1.195 (2.01%)

XLRN

Acceleron

$48.58

-0.08 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 08

    Dec

  • 09

    Dec

  • 11

    Dec

  • 04

    Apr

MNTA

Momenta

$17.53

0.68 (4.04%)

12:04
12/06/19
12/06
12:04
12/06/19
12:04
Hot Stocks
Momenta granted orphan status for hemolytic anemia treatment »

The FDA granted Momenta…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 16

    Dec

EA

Electronic Arts

$102.74

0.66 (0.65%)

, ATVI

Activision Blizzard

$55.08

0.09 (0.16%)

12:03
12/06/19
12/06
12:03
12/06/19
12:03
Conference/Events
Wedbush digital media analyst to hold an analyst/industry conference call »

Digital Media Analyst…

EA

Electronic Arts

$102.74

0.66 (0.65%)

ATVI

Activision Blizzard

$55.08

0.09 (0.16%)

GME

GameStop

$6.46

0.1 (1.57%)

NTDOY

Nintendo

$0.00

(0.00%)

TTWO

Take-Two

$123.21

-0.69 (-0.56%)

UBSFY

Ubisoft

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 13

    Dec

PRVL

Prevail Therapeutics

$14.02

-0.03 (-0.21%)

12:02
12/06/19
12/06
12:02
12/06/19
12:02
Hot Stocks
Prevail Therapeutics granted orphan status for dementia treatment »

The FDA granted Prevail…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEI

Weidai

$4.10

-0.35 (-7.87%)

12:00
12/06/19
12/06
12:00
12/06/19
12:00
Hot Stocks
Weidai falls -8.3% »

Weidai is down -8.3%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.